Zhitong Finance App News, Huahai Pharmaceutical (600521.SH) issued an announcement. The company recently received the “Drug Registration Certificate” for adenosylcobalamin capsules approved and issued by the State Drug Administration. Adenosylcobalamin capsules are suitable for megaloblastic anemia, malnourished anemia, anemia during pregnancy, polyneuritis, radiculitis, trigeminal neuralgia, sciatica, and nerve palsy; they can also be used for adjuvant treatment of nutritional diseases and leukopenia caused by radiation and drugs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.